the purchaser named therein and Jaguar Health
Jaguar Health, Inc. completed acquisition of shares of Napo Therapeutics on September 15, 2026.
Company-confirmed: reported in the company's own SEC filing
Latest update Sep 15, 2026, 5:44 PM ET
- ✓Announced
- ✓Pending
- ✓Completed
Acquirer
Jaguar HealthJAGXTarget
the purchaser named thereinNot US-listed- Deal value
- Not disclosed
- the filing states none
- Offer
- Not disclosed
- Premium
- N/A
- Shown only for a signed all-cash price per share
- Expected close
- Not disclosed
- other
Share prices around the disclosure
Daily closes, each set to 100 on the first day shown. The dashed lines mark the session that first reflects each public event.
